MCL
Clinical trials for MCL explained in plain language.
Never miss a new study
Get alerted when new MCL trials appear
Sign up with your email to follow new studies for MCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail targets tough blood cancer
Disease control Recruiting nowThis study tests a combination of two drugs, glofitamab and lenalidomide, in people with a fast-growing type of blood cancer called mantle cell lymphoma that has come back or not responded to prior treatments, including a BTK inhibitor. About 43 adults will receive the drugs intr…
Matched conditions: MCL
Phase: PHASE2 • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New hope for aggressive lymphoma: targeted combo aims to keep cancer in check
Disease control Recruiting nowThis study tests whether giving the drug glofitamab after an initial treatment with BTKi and rituximab can better control high-risk mantle cell lymphoma (MCL) that has not been treated before. About 30 adults with newly diagnosed, high-risk MCL will receive this two-step approach…
Matched conditions: MCL
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:55 UTC